ChromoSeq
A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 60 patients (estimated)
- Sponsors
- Washington University School of Medicine
- Collaborators
- National Cancer Institute (NCI), Edward P. Evans Foundation
- Tags
- Genetic Sequencing, Laboratory Assay
- Trial Type
- Observational
- Last Update
- 2 months ago
- SparkCures ID
- 1529
- NCT Identifier
- NCT05434598
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.